Concepedia

Author

Emma Ádám

Unified Szent István and Szent László Hospital

Also Known As

Emma Adam, Emma Adám, Emma Ádám

20

Publications

241

Citations

8

H-Index

15

Concepts

All Affiliations

Unified Szent István and Szent László HospitalHungarian National Blood Transfusion ServiceUniversity of PecsSemmelweis University
EÁ

About

Emma Ádám is an author at Unified Szent István and Szent László Hospital specializing in medicine, pathology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

80

2

Pathology

3

3

80

3

Immunology

2

2

49

4

Cell Biology

1

1

34

5

Autoimmunity

1

1

34

Emma Ádám

×

8

Publications

222

Citations

8

H-Index

YearCitations

Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib

Ambrus Gángó, Donát Alpár, Bence Gálik,

International Journal of Cancer

2019

54

Hepatosplenic γδ T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration

Júlia Tamáska, Emma Ádám, András Kozma,

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

2006

34

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia

Magdalena Koszarska, András Bors, Angela Feczko,

Leukemia & lymphoma/Leukemia and lymphoma

2012

31

Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

Nóra Meggyesi, András Kozma, Gabriella Halm,

Acta Haematologica

2011

30

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts

Hajnalka Andrikovics, Sarolta Nahajevszky, Anikó Szilvási,

Hematological Oncology

2007

26

Medium-sized<i>FLT3</i>internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort

Magdalena Koszarska, Nóra Meggyesi, András Bors,

Leukemia & lymphoma/Leukemia and lymphoma

2013

20

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin

Henriette Skribek, Rita Ötvös, Emilie Flaberg,

Experimental Hematology

2010

15

<i><scp>NFKB</scp>1 −</i>94ins/del<scp>ATTG</scp> polymorphism is a novel prognostic marker in first line‐treated multiple myeloma

Gergely Varga, Gábor Mikala, Hajnalka Andrikovics,

British Journal of Haematology

2014

12

Page 1